Additionally, SYNJ1-haploinsufficient AD mouse models (with Swedish APP and PSEN1 exon 9 deletion) exhibited a lower plaque load, reduced amyloid peptide levels, and improved cognition. The gene discussed is APP; the disease is Alzheimer disease.